RxDoctor Payments Data

Glen Poffenbarger, MD

Neurological Surgery · Cody, WYNPI 1669469227

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $33,700 of the $54,653 with a category attached, or 61.7%. 7 manufacturers reported payments, led by GS Solutions, Inc. at 55.1% of the total. 2025 is the largest year on record at $30,445, 4.0 times the $7,642 reported in 2019.

$54,653in general payments, 2019–2025

Across 41 payments — averaging $1332.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GS Solutions, Inc.$30K
  • Globus Medical$16K
  • Intelivation Technologies, LLC$7K
  • Aesculap Implant Systems, LLC$1K
  • Seaspine Orthopedics Corporation$637
  • Medtronic$424
  • plus $14 from 1 others
$128,000in research payments, 2019–2025

Across 3 payments — averaging $42,667 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GS Solutions, Inc.$128K

What the payments were for

  • Royalty or licence$15,87429%
  • Consulting fees$33,70062%
  • Travel & lodging$4,5078%
  • Food & beverage$5721%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GS Solutions, Inc.4$30,093
Globus Medical11$15,894
Intelivation Technologies, LLC7$6,500
Aesculap Implant Systems, LLC7$1,091
Seaspine Orthopedics Corporation5$637
Medtronic6$424
Orthofix Medical, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neurological surgery providers in Wyomingto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$376,472
Medicare patients
526
Services billed
1,866

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl11$6,447
Gabapentin141$1,012
Duloxetine Hcl42$800
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen86$797
Methylprednisolone98$719
Tizanidine Hcl104$653
Celecoxib22$522
Pregabalin20$390
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen21$275
Meloxicam89$247
Tramadol Hcl58$207
Hydromorphone Hcl17$100

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Cody

See the full list for Wyoming

Where these figures come from

Is this you, or does something look wrong? →